BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sumi T, Hirai S, Yamaguchi M, Tanaka Y, Tada M, Yamada G, Hasegawa T, Miyagi Y, Niki T, Watanabe A, Takahashi H, Sakuma Y. Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas. Int J Oncol 2018;53:33-46. [PMID: 29658609 DOI: 10.3892/ijo.2018.4365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Du Y, Li X, Niu Q, Mo X, Qui M, Ma T, Kuo CJ, Fu H. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. J Mol Cell Biol 2020;12:630-43. [PMID: 32678871 DOI: 10.1093/jmcb/mjaa036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
2 Kim K, Kwon O, Ryu TY, Jung CR, Kim J, Min JK, Kim DS, Son MY, Cho HS. Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer. Mol Med Rep 2019;20:1569-74. [PMID: 31257531 DOI: 10.3892/mmr.2019.10431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Chen Z, Li M, Ma K, Shang G, Liang J, Yin J, Luo J, Zhan C, Shi Y, Wang Q. Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma. Cancer Med 2020;9:517-29. [PMID: 31769218 DOI: 10.1002/cam4.2726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Bahar E, Kim JY, Kim DC, Kim HS, Yoon H. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway. Int J Mol Sci 2021;22:3916. [PMID: 33920140 DOI: 10.3390/ijms22083916] [Reference Citation Analysis]
5 Sumi T, Hirai S, Yamaguchi M, Tanaka Y, Tada M, Niki T, Takahashi H, Sakuma Y. Trametinib downregulates survivin expression in RB1-positive KRAS -mutant lung adenocarcinoma cells. Biochemical and Biophysical Research Communications 2018;501:253-8. [DOI: 10.1016/j.bbrc.2018.04.230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu Y, Yu X, Liang M, Wang B. Correlation analysis of expression and prognosis of TTF-1 and CD44v6 in undifferentiated lung carcinoma. Oncol Lett 2019;18:3571-80. [PMID: 31579090 DOI: 10.3892/ol.2019.10689] [Reference Citation Analysis]
7 Li T, Huang L, Yang M. Lipid-based Vehicles for siRNA Delivery in Biomedical Field. Curr Pharm Biotechnol 2020;21:3-22. [PMID: 31549951 DOI: 10.2174/1389201020666190924164152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]